First line tailored chemotherapy in advanced colorectal cancer (ACRC) with 5-fluouracil/leucovorin (5FU/LV) or oxaliplatin/irinotecan chosen by the expression of thymidylate synthase (TS) and dihydropyrimidine (DPD)
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Amsterdam UMC Location Vrije Universiteit Amsterdam
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2259212782
